Kardigan Company

Kardigan is a biopharmaceutical company developing a pipeline of personalized medicines to treat and potentially cure cardiovascular diseases. The company utilizes a proprietary Cardiac Intelligence R&D platform to confirm markers for safety, efficacy, and patient selection before human trials. Kardigan integrates AI-based tools into its clinical trials to optimize study design and increase confidence in results.

Technology: Predictive Toxicology and ADMET Modeling
Industry: BioPharma AI
Founded Date: 2023-01-01 00:00:00
Headquarters: South San Francisco,California,United States,North America
Funding Status: private